Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C175 - Treatment of Pediatric Multiple Sclerosis in the Current Era

Wednesday 04/26/23
03:30 PM - 05:30 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Jennifer Graves, MD, PhD
Child Neurology and Developmental Neurology, Multiple Sclerosis
Participants should be able to understand the approach to the diagnosis of Pediatric MS and unique features of the disease in children; summarize current literature regarding treatments for acute relapses and for disease modulation; and address symptomatic management, cognitive symptoms, mental wellness and physical activity, and strategies for rehabilitation.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:00 PM EST Speaker Unique Features of Pediatric MS and Overview of the Therapeutic Landscape
Jennifer Graves, MD, PhD
04:00 PM - 04:30 PM EST Speaker The Nuts and Bolts of Disease-modifying Therapies in Children
Jennifer H. Yang, MD
04:30 PM - 05:00 PM EST Speaker Beyond DMTs: Symptom Management, Physical Activity and Mental Wellness in Pediatric MS
James Nick Brenton, MD
05:00 PM - 05:30 PM EST Discussion Questions, Answers, and Case Examples
Jennifer Graves, MD, PhD, James Nick Brenton, MD, Jennifer H. Yang, MD
Faculty Disclosures
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
James Nick Brenton, MD Dr. Brenton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharmaceuticals. The institution of Dr. Brenton has received research support from NIH/NINDS. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Expert Interview with MDEdge. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH.
Jennifer H. Yang, MD Dr. Yang has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. The institution of Dr. Yang has received research support from Pediatric Epilepsy Research Foundation. The institution of Dr. Yang has received research support from UCB.